Beximco`s 8th drug gets FDA approval...

Dhaka, Thursday   29 October 2020

Beximco`s 8th drug gets FDA approval

 Staff Correspondent

 Published: 12:13 PM, 22 September 2020  

Beximco`s 8th drug gets FDA approval

Beximco`s 8th drug gets FDA approval

Beximco Pharmaceuticals Limited has received approval from the Food and Drug Administration (FDA) of United States for selling Flecainide Acetate, an antiarrhythmic drug in the US market.

Flecainide Acetate medicine is used for treating irregular heartbeats in conditions such as tachycardia and atrial fibrillation, said a press release.

This is Beximco Pharma’s eighth Abbreviated New Drug Application (ANDA) which has been successfully approved for the US market.

Nazmul Hassan MP, Managing Director of Beximco Pharmaceuticals, said "This approval is another important step in building and strengthening our presence in the US market.”

He said that since its inception in 1976, Beximco Pharma has been gradually spreading its area abroad. The company's drugs are approved by international regulatory authorities in the United States, Europe, Australia, Canada, and Brazil.